SightfileU.S. market data from official filings

Companies › ZNTL

ZENTALIS PHARMACEUTICALS INC (ZNTL)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001725160 · EDGAR filings · Updated 2026-06-18

ZENTALIS PHARMACEUTICALS INC (ZNTL) has reported institutional ownership of 61.4%, with 102 institutional managers holding positions valued at $101.7M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
61.4%
Institutional managers
102
Reported 13F value
$101.7M
Insider activity
17 trans.
−$2.33M net selling
Data flags
2 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ZENTALIS PHARMACEUTICALS INC has 102 institutional holders and institutional ownership of 61.4%.

Insider activity

Insiders reported 17 transactions (2 buys, 10 sells) across 10 reporting insiders, with a net reported value of −$2.33M.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-12 (recurring since 2020-05-15) — source filing. The authoritative details are those stated in the filing itself.
Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2024-01-25 (recurring since 2022-05-24) — source filing. The authoritative details are those stated in the filing itself.

Related companies

PRELUDE THERAPEUTICS INC (PRLD) · ELECTROMED INC (ELMD) · SILENCE THERAPEUTICS PLC (SLN) · COHERUS ONCOLOGY INC (CHRS) · FENNEC PHARMACEUTICALS INC (FENC) · Sol-Gel Technologies Ltd (SLGL)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-18.